The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Medefil sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Medefil is a specialty pharmaceutical company that develops, manufactures, and sells injectable products and prefilled flush syringes. The company’s product portfolio includes sterile water for injection, calcium chloride injection, sodium chloride injection, normal saline I.V. flush syringes, and Heparin Lock flush syringes. Its products find application in critical care, pain, and anti-infective therapy areas. Medefil is also developing critical injectables and complex injectables for use in pain, critical care, anti-infective and anti-injective therapy areas. The company also provides contract manufacturing of prefilled diluent syringes. Medefil is headquartered in Glendale Heights, Illinois, the US.
The key metrics of Medefil related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Medefil is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Medefil.
For a detailed understanding of the performance of Medefil, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
